116 related articles for article (PubMed ID: 20876794)
1. Key role of phosphoinositide 3-kinase class IB in pancreatic cancer.
Edling CE; Selvaggi F; Buus R; Maffucci T; Di Sebastiano P; Friess H; Innocenti P; Kocher HM; Falasca M
Clin Cancer Res; 2010 Oct; 16(20):4928-37. PubMed ID: 20876794
[TBL] [Abstract][Full Text] [Related]
2. The kinase Mirk/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma.
Deng X; Ewton DZ; Li S; Naqvi A; Mercer SE; Landas S; Friedman E
Cancer Res; 2006 Apr; 66(8):4149-58. PubMed ID: 16618736
[TBL] [Abstract][Full Text] [Related]
3. PKC Delta (PKCdelta) promotes tumoral progression of human ductal pancreatic cancer.
Mauro LV; Grossoni VC; Urtreger AJ; Yang C; Colombo LL; Morandi A; Pallotta MG; Kazanietz MG; Bal de Kier Joffé ED; Puricelli LL
Pancreas; 2010 Jan; 39(1):e31-41. PubMed ID: 19924022
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1.
Guha S; Rey O; Rozengurt E
Cancer Res; 2002 Mar; 62(6):1632-40. PubMed ID: 11912133
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
6. Upregulated histone deacetylase 1 expression in pancreatic ductal adenocarcinoma and specific siRNA inhibits the growth of cancer cells.
Gao DJ; Xu M; Zhang YQ; Du YQ; Gao J; Gong YF; Man XH; Wu HY; Jin J; Xu GM; Li ZS
Pancreas; 2010 Oct; 39(7):994-1001. PubMed ID: 20467347
[TBL] [Abstract][Full Text] [Related]
7. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
[TBL] [Abstract][Full Text] [Related]
9. PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
Schild C; Wirth M; Reichert M; Schmid RM; Saur D; Schneider G
Mol Carcinog; 2009 Dec; 48(12):1149-58. PubMed ID: 19603422
[TBL] [Abstract][Full Text] [Related]
10. A sensitized RNA interference screen identifies a novel role for the PI3K p110γ isoform in medulloblastoma cell proliferation and chemoresistance.
Guerreiro AS; Fattet S; Kulesza DW; Atamer A; Elsing AN; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
Mol Cancer Res; 2011 Jul; 9(7):925-35. PubMed ID: 21652733
[TBL] [Abstract][Full Text] [Related]
11. The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer.
Jin K; Park S; Ewton DZ; Friedman E
Cancer Res; 2007 Aug; 67(15):7247-55. PubMed ID: 17671193
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
13. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth.
Iiizumi M; Hosokawa M; Takehara A; Chung S; Nakamura T; Katagiri T; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Sci; 2006 Nov; 97(11):1211-6. PubMed ID: 16965393
[TBL] [Abstract][Full Text] [Related]
14. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells.
Hehlgans S; Eke I; Storch K; Haase M; Baretton GB; Cordes N
Radiother Oncol; 2009 Sep; 92(3):362-70. PubMed ID: 19665245
[TBL] [Abstract][Full Text] [Related]
16. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
[TBL] [Abstract][Full Text] [Related]
17. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
[TBL] [Abstract][Full Text] [Related]
18. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
19. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
20. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
